Skip to main content
. 2022 Nov 7;14(11):2403. doi: 10.3390/pharmaceutics14112403

Figure 4.

Figure 4

(A) Overlay plot representing area of optimized formula for XH-SLNs. (B) Predicted and observed values of the optimized batch of XH-SLNs.